Primary literature evidence
Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.
Evidence records
Table 3: XOI Activity of IC50 (mM) for WDDMEKIW is 3.16 ± 0.03. Text: 'The XOI activities of the peptides were highest in WW8 (IC50 = 3.16 ± 0.03 mM)'.
Table 3: XOI Activity of IC50 (mM) for APPERKYSVW is 5.86 ± 0.02. Text: 'AW10 (IC50 = 5.86 ± 0.02 mM)'.
Table 3: XOI Activity of IC50 (mM) for IADRMQKELT is NA. Text: 'IADRMQKELT and LNSADLIK had no XOI activity at 15 mg/mL'.
Table 3: XOI Activity of IC50 (mM) for LNSADLIK is NA. Text: 'IADRMQKELT and LNSADLIK had no XOI activity at 15 mg/mL'.
Table 3: XOI Activity of IC50 (mM) for LSNLGIVI is NA. Text: 'LSNLGIVI, IGALRAVA, and HHTFYNELR did not even dissolve in water at 3 mg/mL, so these five peptides were neglected for the subsequent experiments.'
Table 3: XOI Activity of IC50 (mM) for IGALRAVA is NA. Text: 'LSNLGIVI, IGALRAVA, and HHTFYNELR did not even dissolve in water at 3 mg/mL, so these five peptides were neglected for the subsequent experiments.'
Table 3: XOI Activity of IC50 (mM) for HHTFYNELR is NA. Text: 'LSNLGIVI, IGALRAVA, and HHTFYNELR did not even dissolve in water at 3 mg/mL, so these five peptides were neglected for the subsequent experiments.'
Table 3: ACE IC50 Seq1 (GGGPGPM) 16.12 ± 2.11 mM. Note: ACE, angiotensin-converting enzyme.
Table 3: DPP-IV IC50 Seq1 (GGGPGPM) 1.26 ± 0.15 mM. Note: DPP-IV, dipeptidyl peptidase IV.
Table 3: ACE IC50 Seq2 (GPPGPAGPAG) 13.13 ± 1.63 mM.
Table 3: DPP-IV IC50 Seq2 (GPPGPAGPAG) 0.82 ± 0.09 mM.
Table 3: ACE IC50 Seq3 (FGFDGDF) ND (not detected). Text: 'The IC50 value on ACE of FGFDGDF was not determined due to its low predicted score as AHTP'.
Table 3: DPP-IV IC50 Seq3 (FGFDGDF) 0.59 ± 0.07 mM.
Table 3: ACE IC50 Seq4 (GPAGPAGPIGPVG) 17.07 ± 2.45 mM.
Table 3: DPP-IV IC50 Seq4 (GPAGPAGPIGPVG) 0.07 ± 0.01 mM. Text: 'GPAGPAGPIGPVG had the best inhibition ability on DPP-IV, with a low IC50 value of 0.07 ± 0.01 mM'.
Table 3: ACE IC50 Seq5 (AGPAGPAGPAGPR) 11.7 ± 1.34 mM.
Table 3: DPP-IV IC50 Seq5 (AGPAGPAGPAGPR) 4.56 ± 0.57 mM.
Table 3: ACE IC50 Seq6 (PGPMGPSGPR) 7.73 ± 0.54 mM. Text: 'only PGPMGPSGPR had an IC50 value below 10 mM'.
Table 3: DPP-IV IC50 Seq6 (PGPMGPSGPR) 3.74 ± 0.52 mM.
Table 3: ACE IC50 Seq7 (PAGPAGPIGPV) 15.42 ± 2.08 mM.
Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.
